Crizalk 250mg Capsule
Marketer
Pfizer Ltd
Salt Composition
Crizotinib (250mg)
Overview Crizalk 250mg Capsule
Avelox 250mg capsules are indicated for managing advanced non-small cell lung cancer, including metastatic disease. Ingestion may occur with or without food, but consistent daily timing maximizes therapeutic effect. Dosage and frequency are determined by your physician, tailored to your condition and potentially adjusted over time. Adhere strictly to your doctor's instructions; improper usage or overdose risks severe adverse reactions. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical guidance. Common side effects include nausea, vomiting, swelling, and diarrhea. Seek immediate medical attention for serious side effects such as intense abdominal pain, fever, chills, dyspnea, tachycardia, visual disturbances, or altered bowel function. Liver function monitoring via blood tests may be part of your treatment plan. Inform your physician of pre-existing cardiac, hepatic, or renal conditions, and all concurrent medications, including antibiotics, as drug interactions are possible. This medication is contraindicated during pregnancy and lactation; effective contraception for both partners is crucial. A patient support program, facilitated by Tata 1mg, exists in India; contact your physician or call (1800-102-1618) for further information.
Uses of Crizalk 250mg Capsule
Lung cancer (excluding small cell)
Major Benefits of Crizalk 250mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Crizalk 250mg Capsules. These capsules can be ingested with or without food, although consistent timing is recommended.
Common Side effects of Crizalk 250mg Capsule:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal pain
- Visual impairment
- Dizziness
- Taste change
- Fatigue
- Decreased appetite
- Rash
- Decreased white blood cell count (neutrophils)
How to use Crizalk 250mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Crizalk 250mg Capsules can be administered with or without food, though consistent timing is recommended.
How Crizalk 250mg Capsule works:
Crizalk 250mg capsules are prescribed for cancer treatment. Their mechanism of action involves inhibiting a faulty protein responsible for triggering uncontrolled cancer cell proliferation, thus hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Crizalk 250mg Capsule is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Crizalk 250mg capsules during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated, except in potentially life-threatening circumstances where a physician deems the potential benefits outweigh the risks. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Crizalk 250mg capsules while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking a Crizalk 250mg capsule might cause drowsiness, blurred vision, and dizziness, reducing your alertness. Refrain from driving if you experience these effects.
KidneyCAUTION
For individuals with severe kidney impairment, Crizalk 250mg capsules require careful administration. Dosage modification of Crizalk 250mg capsules may be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Crizalk 250mg capsules; dosage modification may be necessary. Consult a physician before use. Crizalk 250mg capsules may be unsuitable for patients experiencing severe hepatic dysfunction.
What if you forget to take Crizalk 250mg Capsule :
Omit any missed Crizalk 250mg Capsule dose and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Crizalk 250mg Capsule
| Label | Value |
|---|---|
| Chemical Category | Piperidine and Aminopyridine Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | TKIs |
3,018 People bought this recently